Winstonepoint Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.35 M
as on 11-01-2025
- Paid Up Capital ₹ 0.35 M
as on 11-01-2025
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
About Winstonepoint Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.35 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Sharad Alhat, Rahul Gosavi, Balu Hadawale, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999PN2017PTC171444
- Company No.
171444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2017
- Date of AGM
30 Oct 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Winstonepoint Pharmaceuticals?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Alhat  | Director | 13-Jul-2017 | Current |
| Rahul Gosavi | Additional Director | 25-Jul-2018 | Current |
| Balu Hadawale | Additional Director | 25-Jul-2018 | Current |
| Chandrashekar Ingle | Director | 13-Jul-2017 | Current |
| Rajendra Khandagale | Director | 13-Jul-2017 | Current |
| Dattatraya Shewale | Additional Director | 25-Jul-2018 | Current |
Financial Performance of Winstonepoint Pharmaceuticals.
Winstonepoint Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Winstonepoint Pharmaceuticals?
In 2018, Winstonepoint Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prowings Health Solution Private LimitedActive 6 years 5 monthsRahul Gosavi, Chandrashekar Ingle and 2 more are mutual person
Saialexin Pharmaceutical Private LimitedActive 8 years 7 monthsSharad Alhat and Balu Hadawale are mutual person
- Vinayshil Krushi Farmers Producer Company LimitedActive 2 years 9 months
Balu Hadawale is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Winstonepoint Pharmaceuticals?
Unlock and access historical data on people associated with Winstonepoint Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winstonepoint Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winstonepoint Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
